Latest News & Updates
Breaking News
1 hour ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
FDA Finalizes ICH Q9(R1) Guidance Targeting Subjectivity and Formality Gaps in Quality Risk Management
FDA finalizes ICH Q9(R1), targeting subjectivity, formality gaps, and product availability risks in pharmaceutical quality risk management frameworks.
Pharma Now Editorial Team
FDA Approves Cefepime/Zidebactam Injection, Raising Sterile Manufacturing and QA Readiness Questions
FDA approves Cefepime/Zidebactam Injection, a novel beta-lactam combination targeting gram-negative pathogens, with sterile manufacturing implications.
Pharma Now Editorial Team
FDA Issues Draft Guidance Streamlining Nonclinical Safety Studies for Oncology Biologics
FDA's draft guidance on oncology biologics nonclinical studies introduces single-species testing and weight-of-evidence NHP alternatives. Comment deadline: July 30, 2026.
Pharma Now Editorial Team
Johnson & Johnson Gains EMA Submission for Teclistamab Indication Extension After Phase 3 MajesTEC-9 OS Win
J&J submits EMA application for teclistamab indication extension after MajesTEC-9 Phase 3 data show 71% PFS and 40% OS benefit at first relapse.
Pharma Now Editorial Team
